| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/00001721-199606000-00005 |
| P698 | PubMed publication ID | 8839998 |
| P2093 | author name string | M Hoffman | |
| D M Monroe | |||
| H R Roberts | |||
| P433 | issue | 4 | |
| P304 | page(s) | 459-464 | |
| P577 | publication date | 1996-06-01 | |
| P1433 | published in | Blood Coagulation and Fibrinolysis | Q15752432 |
| P1476 | title | Transmission of a procoagulant signal from tissue factor-bearing cell to platelets | |
| P478 | volume | 7 |
| Q37494353 | A Phase 2, randomized, partially blinded, active-controlled study assessing the efficacy and safety of variable anticoagulation reversal using the REG1 system in patients with acute coronary syndromes: results of the RADAR trial |
| Q36146339 | A review of the clinical utility of INR to monitor and guide administration of prothrombin complex concentrate to orally anticoagulated patients |
| Q37550053 | Catheter thrombosis and percutaneous coronary intervention: fundamental perspectives on blood, artificial surfaces and antithrombotic drugs |
| Q47993086 | Clots Are Potent Triggers of Inflammatory Cell Gene Expression: Indications for Timely Fibrinolysis. |
| Q64093592 | Coagulation Pathways in Neurological Diseases: Multiple Sclerosis |
| Q35775912 | Coagulation in sepsis |
| Q38400558 | Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): a randomised clinical trial |
| Q88961956 | Experimental hypercoagulable state induced by tissue factor expression in monocyte-derived dendritic cells and its modulation by C1 inhibitor |
| Q47164838 | Factor VII deficiency: a novel missense variant and genotype-phenotype correlation in patients from Southern Italy |
| Q55241963 | In vitro and in vivo evaluation of the effect of elevated factor VIII on the thrombogenic process. |
| Q34242634 | Links between the immune and coagulation systems: how do "antiphospholipid antibodies" cause thrombosis? |
| Q36284640 | Mechanistic implications for the use and monitoring of recombinant activated factor VII in trauma |
| Q38257119 | Novel antiplatelet agents in acute coronary syndrome |
| Q43594298 | Oral factor Xa inhibitors for the long-term management of ACS. |
| Q26775125 | Personalized antiplatelet therapy with P2Y12 receptor inhibitors: benefits and pitfalls |
| Q73163227 | Platelet-induced thrombin generation time II (PITT II). A modified global coagulation test to monitor prophylactic anticoagulation with vitamin K antagonists? |
| Q35342220 | Positive feedback loops for factor V and factor VII activation supply sensitivity to local surface tissue factor density during blood coagulation. |
| Q34335937 | Rapid vascular responses to anthrax lethal toxin in mice containing a segment of chromosome 11 from the CAST/Ei strain on a C57BL/6 genetic background |
| Q34294608 | Remodeling the blood coagulation cascade |
| Q35198502 | Soluble phosphatidylserine binds to two sites on human factor IXa in a Ca2+ dependent fashion to specifically regulate structure and activity |
| Q33820975 | Task-oriented modular decomposition of biological networks: trigger mechanism in blood coagulation |
| Q35181738 | The participation of leukocytes in coagulant reactions |
| Q47369963 | The role of oral anticoagulant therapy in patients with acute coronary syndrome |
| Q36439538 | Thrombin activity propagates in space during blood coagulation as an excitation wave |
| Q36691794 | Thrombin generation, fibrin clot formation and hemostasis |
| Q37809781 | Translating Nucleic Acid Aptamers to Antithrombotic Drugs in Cardiovascular Medicine |
| Q36987361 | Translation and Clinical Development of Antithrombotic Aptamers |
| Q38378483 | Viscoelasticity and Ultrastructure in Coagulation and Inflammation: Two Diverse Techniques, One Conclusion |
Search more.